ARGX FY 2024 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.2B+78.6% YoY

Gross Profit

$2.0B89.6% margin

Operating Income

-$22M-1.0% margin

Net Income

$833M38.0% margin

EPS (Diluted)

$12.78

Cash Flow

Operating Cash Flow

-$83M

Free Cash Flow

-$151M

Stock-Based Comp.

$235M

Balance Sheet

Total Assets

$6.2B

Total Liabilities

$704M

Stockholders' Equity

$5.5B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.2B	$1.2B	+78.6%
Gross Profit	$2.0B	$1.1B	+77.1%
Operating Income	-$22M	-$425M	+94.9%
Net Income	$833M	-$295M	+382.3%